De Nobrega, D.D.; Eiler, L.C.; Ahirwar, P.; Nallapu, S.; Rawal, U.P.; Crawford, C.L.; Buchsbaum, D.J.; Keeton, A.B.; Maxuitenko, Y.Y.; Chen, X.;
et al. Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor Models. Cancers 2025, 17, 2958.
https://doi.org/10.3390/cancers17182958
AMA Style
De Nobrega DD, Eiler LC, Ahirwar P, Nallapu S, Rawal UP, Crawford CL, Buchsbaum DJ, Keeton AB, Maxuitenko YY, Chen X,
et al. Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor Models. Cancers. 2025; 17(18):2958.
https://doi.org/10.3390/cancers17182958
Chicago/Turabian Style
De Nobrega, Daniela D., Logan C. Eiler, Parmanand Ahirwar, Sonika Nallapu, Urvi P. Rawal, Chelsea L. Crawford, Donald J. Buchsbaum, Adam B. Keeton, Yulia Y. Maxuitenko, Xi Chen,
and et al. 2025. "Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor Models" Cancers 17, no. 18: 2958.
https://doi.org/10.3390/cancers17182958
APA Style
De Nobrega, D. D., Eiler, L. C., Ahirwar, P., Nallapu, S., Rawal, U. P., Crawford, C. L., Buchsbaum, D. J., Keeton, A. B., Maxuitenko, Y. Y., Chen, X., Piazza, G. A., Tsung, A., & Budhwani, K. I.
(2025). Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor Models. Cancers, 17(18), 2958.
https://doi.org/10.3390/cancers17182958